Literature DB >> 12630753

Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus.

M R Arbuckle1, J A James, G J Dennis, M V Rubertone, M T McClain, X R Kim, J B Harley.   

Abstract

The initial clinical course of systemic lupus erythematosus (SLE) is variable, ranging from relatively minor manifestations progressing over years to rapid onset of fulminate disease. We sought to identify factors associated with the rapid manifestation of SLE. Chart review of military medical records was used to identify 130 patients who met the American College of Rheumatology classification criteria for SLE. Demographics, clinical criteria date of occurrence, and the date of SLE classification (at least four clinical criteria) met were documented. Prospectively stored serum samples prior to the diagnosis were evaluated for SLE autoantibodies. Median time from the first recorded criteria to diagnosis was significantly shorter in African-American (AA) males compared with AA females and European American (EA) females and males combined. AA males were more likely to have nephritis as their first clinical symptom. Also, less time transpired between the first clinical criterion and SLE diagnosis in AA males with nephritis than in other groups presenting with nephritis. Even when cases presenting with nephritis were excluded, a diagnosis of SLE was made more rapidly in AA males. African-American men progress from initial clinical manifestations to SLE diagnosis more rapidly than other ethnic or gender groups.

Entities:  

Mesh:

Year:  2003        PMID: 12630753     DOI: 10.1191/0961203303lu334oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  26 in total

Review 1.  Ethnic disparities in patients with systemic lupus erythematosus.

Authors:  América G Uribe; Graciela S Alarcón
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.

Authors:  Lauren L Ritterhouse; Sherry R Crowe; Timothy B Niewold; Joan T Merrill; Virginia C Roberts; Amy B Dedeke; Barbara R Neas; Linda F Thompson; Joel M Guthridge; Judith A James
Journal:  Arthritis Rheum       Date:  2011-12

3.  Male-only systemic lupus.

Authors:  Rachna Aggarwal; Bahram Namjou; Shibo Li; Anil D'Souza; Betty P Tsao; Benjamin F Bruner; Judith A James; R Hal Scofield
Journal:  J Rheumatol       Date:  2010-05-15       Impact factor: 4.666

4.  Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides.

Authors:  Latisha D Heinlen; Lauren L Ritterhouse; Micah T McClain; Michael P Keith; Barbara R Neas; John B Harley; Judith A James
Journal:  J Mol Med (Berl)       Date:  2010-04-17       Impact factor: 4.599

5.  Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.

Authors:  J Ren; X Liao; M D Vieson; M Chen; R Scott; J Kazmierczak; X M Luo; C M Reilly
Journal:  Clin Exp Immunol       Date:  2017-10-16       Impact factor: 4.330

6.  60 kD Ro and nRNP A frequently initiate human lupus autoimmunity.

Authors:  Latisha D Heinlen; Micah T McClain; Lauren L Ritterhouse; Benjamin F Bruner; Colin C Edgerton; Michael P Keith; Judith A James; John B Harley
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

7.  Male gender results in more severe lupus nephritis.

Authors:  Jozélio Freire de Carvalho; Ana Patrícia do Nascimento; Leonardo A Testagrossa; Rui Toledo Barros; Eloísa Bonfá
Journal:  Rheumatol Int       Date:  2009-09-27       Impact factor: 2.631

Review 8.  Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases.

Authors:  Jin-Bao Feng; Jin-Dong Ni; Xi Yao; Hai-Feng Pan; Xiang-Pei Li; Jian-Hua Xu; Fa-Ming Pan; Sheng-Qian Xu; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2009-08-23       Impact factor: 2.631

9.  Sex differences in patients with systemic lupus erythematosus from Northwest Spain.

Authors:  Maria D Alonso; Francisco Martínez-Vázquez; Leyre Riancho-Zarrabeitia; Teresa Díaz de Terán; Jose A Miranda-Filloy; Ricardo Blanco; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Rheumatol Int       Date:  2013-06-28       Impact factor: 2.631

10.  Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.

Authors:  David Isenberg; Gerald B Appel; Gabriel Contreras; Mary A Dooley; Ellen M Ginzler; David Jayne; Jorge Sánchez-Guerrero; David Wofsy; Xueqing Yu; Neil Solomons
Journal:  Rheumatology (Oxford)       Date:  2009-11-20       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.